Health Technology Assessment (HTA)
Health Technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine a health technology’s value for healthcare decision-making. Attitudes towards HTA vary globally, with some countries using a variety of methods and analyses and others hardly any.
Valuing Health at the End of Life: Public Preferences
13 October 2011
In 2009, the UK’s National Institute for Health and Clinical Excellence (NICE) issued supplementary advice that its Appraisal Committees are to consider when assessing treatments that…
Join OHE at ISPOR: MCDA, Risk Sharing and Value-Based Pricing
4 October 2011
Join OHE at ISPOR to discuss multiple criteria decision analysis, value based pricing, risk sharing, post-approval data collection and other key topics in HTA and health…
OHE in the Spotlight: Summer 2011
22 September 2011
This is the first in a series of posts that will review OHE’s contributions to advancing thought and stimulating innovative ideas in its three key research…
HTA and Appropriate Drug Pricing Worldwide
9 September 2011
The August 2011 issue of Health Affairs featured four articles on how and why pricing for pharmaceuticals differs from one country to another. The OHE’s Prof…
Incentives for R&D for New Antimicrobial Drugs
31 August 2011
Just published by OHE researchers is a comprehensive analysis of what policy measures are needed to counter the growing global problem of antimicrobial resistance. Their key…
Recent Statistics on Orphan Approvals in Scotland and England
23 August 2011
In October 2009, the OHE published research that compared access to orphan medicinal products (OMPs) in selected European countries. At the request of the UK Orphan…
New: Operationalising Value Based Pricing
11 August 2011
To date, the UK Government has not been specific about how VBP will be implemented, but has indicated that calculations of value will extend beyond the…
Does Relative Effectiveness Vary Across Europe?
9 August 2011
At the Spanish Health Economics Association (AES) conference in May 2011, OHE’s Ruth Puig Peiró discussed a recent OHE study that reviewed the available literature on…
Previews of Forthcoming Publications
27 July 2011
OHE is making available as Occasional Papers drafts of two important chapters that will appear in the Oxford Handbook on the Economics of the Pharmaceutical Industry…